1. Home
  2. ENOV vs IVA Comparison

ENOV vs IVA Comparison

Compare ENOV & IVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Enovis Corporation

ENOV

Enovis Corporation

HOLD

Current Price

$26.21

Market Cap

1.4B

Sector

Industrials

ML Signal

HOLD

Logo Inventiva S.A. American Depository Shares

IVA

Inventiva S.A. American Depository Shares

HOLD

Current Price

$5.70

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ENOV
IVA
Founded
1995
2011
Country
United States
France
Employees
N/A
77
Industry
Fluid Controls
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.1B
IPO Year
2008
N/A

Fundamental Metrics

Financial Performance
Metric
ENOV
IVA
Price
$26.21
$5.70
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
10
Target Price
$47.38
$16.20
AVG Volume (30 Days)
611.7K
467.6K
Earning Date
05-07-2026
03-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$6.36
N/A
Revenue Next Year
$5.31
$751.20
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$21.00
$2.94
52 Week High
$36.82
$7.98

Technical Indicators

Market Signals
Indicator
ENOV
IVA
Relative Strength Index (RSI) 66.37 49.27
Support Level $25.97 $3.86
Resistance Level $26.41 $5.78
Average True Range (ATR) 0.96 0.38
MACD 0.36 0.04
Stochastic Oscillator 85.25 83.15

Price Performance

Historical Comparison
ENOV
IVA

About ENOV Enovis Corporation

Enovis Corp is a medical technology manufacturer and distributor of medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy. Its products support patient care from injury prevention through post-surgical or post-injury rehabilitation and treatment of degenerative conditions. The company's reportable segments include Prevention & Recovery and Reconstructive segments. The majority of revenueis derived from the Prevention & Recovery segment, which includes products that are used by orthopedic specialists, primary care physicians, physical therapists, chiropractors, athletic trainers and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformitiesand sports-related injuries.

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

Share on Social Networks: